Cargando…
Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor
The inflammatory process implicates homeostasis disruption and increased production of inflammatory mediators. Myeloid differentiation primary response 88 (MyD88) is an essential protein recruited after lipopolysaccharide (LPS) and interleukin (IL)-1β stimulation, a process that converges in nuclear...
Autores principales: | Ramírez-Pérez, Sergio, Hernández-Palma, Luis Alexis, Oregon-Romero, Edith, Anaya-Macías, Brian Uriel, García-Arellano, Samuel, González-Estevez, Guillermo, Muñoz-Valle, José Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570868/ https://www.ncbi.nlm.nih.gov/pubmed/32967164 http://dx.doi.org/10.3390/molecules25184322 |
Ejemplares similares
-
Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients
por: Ramirez-Perez, Sergio, et al.
Publicado: (2021) -
MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients
por: Ramirez-Perez, Sergio, et al.
Publicado: (2023) -
Disrupting myddosome assembly in diffuse large B-cell lymphoma cells using the MYD88 dimerization inhibitor ST2825
por: Wang, Xin, et al.
Publicado: (2019) -
The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer
por: Lu, Sinan, et al.
Publicado: (2023) -
MyD88-dependent Dendritic and Epithelial Cell Crosstalk Orchestrates Immune Responses to Allergens
por: Thomas, Seddon Y., et al.
Publicado: (2017)